Large-scale testing (Phase 3)Study completedNCT03231800
What this trial is testing
Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Who this might be right for
Attention-Deficit Hyperactivity Disorder (ADHD)
Sumitomo Pharma America, Inc. 95